Clinical Trial: Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07735819) titled 'Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma' on July 24.

Brief Summary: The goal of this clinical trial is to evaluate Positron emission tomography/computed tomography (PET/CT) imaging with the radiotracer 1-(2-[18F]fluoroethyl)-l-tryptophan ([18F]FETrp) in patients diagnosed with a glioma. This study has 3 aims:

* to assess if the [18F]FETrp PET/CT can outperform Magnetic Resonance Imaging (MRI) by providing a better treatment target volume in newly diagnosed Stage 4 glioma patients

* better differentiate tumor progression from radiation induced MRI changes in post treatme...